Case File
efta-02077573DOJ Data Set 10OtherEFTA02077573
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02077573
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Barrett Paul S
From:
Sent:
Wed 5/27/2015 10:18:42 PM
Subject:
Re: Jeffrey Epstein
I believe Thursday or Friday will work but still sorting out! Let me get back to
you!
Sent from my iPhone
> On May 27, 2015, at 5:58 PM, Barrett, Paul S
wrote:
> Hi
> That is the only day next week that does not work. Any other days?
>
• Paul Barrett I Managing Director I Global Investment Opportunities Group I J.P.
Morgan Securities LLC I
J.P. Morgan Private Bank I J.P. Morgan Chase Bank N.A.
> 320 Park Avenue, 14th Floor, New York, NY 10022 I T: (212) 622-2770 I F: (212)
310-0108 I
> NOT AN OFFICIAL CONFIRMATION: For informational purposes only. This report
does not represent an official account of the holdings, balances, or transactions
made in your account and is being provided at your request. Please refer to your
monthly account statement for the official record of all of your account
activities. For question, please call your J.P. Morgan representative.
> In discussion of options and other strategies, results and risks are based
solely on hypothetical examples cited; actual results and risks will vary
depending on specific circumstances. Investors are urged to consider carefully
whether option or option-related products in general, as well as the products or
strategies discussed herein are suitable to their needs. In actual transactions,
the client's counterparty for OTC derivatives applications is JPMorgan chase
Bank, N.A., and affiliates. For a copy of the "Characteristics and Risks of
Standardized Options" booklet, please contact your JPMorgan Advisor.
> This email is confidential and subject to important disclaimers and conditions
including on offers for the purchase or sale of securities, accuracy and
completeness of information, viruses, confidentiality, legal privilege, and legal
entity disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.
•
Original Message
> From:
(mailto
> Sent: Wednesday, May 27, 2015 4:28 PM
> To: Barrett, Paul S
> Subject: Jeffrey Epstein
> Hello Paul. Hope you are well...might you be available to come see Jeffrey on
Wed. June 3? Perhaps 3:15?
> Please let me know..thank you,
>
• This email is confidential and subject to important disclaimers and conditions
including on offers for the purchase or sale of securities, accuracy and
completeness of information, viruses, confidentiality, legal privilege, and
legal entity disclaimers, available at
http://www.jpmorgan.com/pages/disclosures/email
EFTA_R1_00655408
EFTA02077573
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
(212) 622-2770Phone
310-0108SWIFT/BIC
OFFICIALURL
http://www.jpmorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.